NEW YORK (GenomeWeb) – Roche today announced it received the CE-IVD mark for the Cobas TV/MG test for use on the Cobas 6800/8800 systems.

The test allows for the direct detection of Trichomonas vaginalis and/or Mycoplasma genitalium DNA in symptomatic as well as asymptomatic patients. Roche launched the test today.